Our Pricing

Aciclovir vs Valaciclovir UK: Expert Clinical Comparison

Published on: June 03, 2026

When comparing aciclovir vs valaciclovir UK treatment options, understanding the key differences in bioavailability, dosing frequency, and clinical effectiveness helps you choose the right cold sore medication. Both antivirals are licensed by the MHRA for herpes simplex virus treatment, but they differ significantly in how your body processes them and how often you need to take them.

How Aciclovir and Valaciclovir Work Against Cold Sores

Aciclovir is a synthetic nucleoside analogue that works by inhibiting viral DNA replication in cells infected with herpes simplex virus type 1 (HSV-1). Once inside infected cells, aciclovir is converted by viral enzymes into its active form, which then blocks the viral DNA polymerase enzyme, preventing the virus from multiplying [1].

Valaciclovir is actually a prodrug of aciclovir — meaning it converts to aciclovir in your body after absorption. The critical difference lies in bioavailability: valaciclovir achieves 54% oral bioavailability compared to just 15-20% for standard aciclovir tablets [2]. This threefold increase in absorption means valaciclovir delivers higher blood levels of active drug with fewer daily doses.

Both medications target the same viral enzyme and produce identical antiviral effects once converted to active aciclovir in your system. The distinction isn't in what they do, but in how efficiently your body can use them.

Dosing Frequency: Aciclovir vs Valaciclovir UK Guidelines

For cold sore treatment, standard aciclovir tablets require five doses daily (200mg five times per day) for five days, with doses spaced approximately four hours apart during waking hours [1]. This frequent dosing schedule can be challenging for patients with busy work schedules or those who struggle with medication adherence.

Valaciclovir's superior bioavailability allows for simplified dosing: typically 500mg twice daily for five days for cold sore treatment [2]. Some prescribers may recommend single-day high-dose regimens (2000mg twice daily for one day) for patients who start treatment at the very first sign of prodromal symptoms [3].

Topical aciclovir cream, such as the Numark Cold Sore Cream available at Cured Pharmacy from £4.49, requires application five times daily to the affected area. While topical treatment avoids systemic absorption, clinical trials show oral antivirals generally produce faster healing times than cream formulations when started early [4].

Which Dosing Schedule Suits Your Lifestyle?

If you work shifts, travel frequently, or simply prefer fewer daily doses, valaciclovir's twice-daily schedule may improve adherence compared to aciclovir's five-times-daily regimen. However, if cost is your primary concern and you can manage frequent dosing, standard aciclovir tablets remain highly effective when taken as prescribed. Your UK prescriber will consider your lifestyle, medical history, and treatment preferences during your clinical assessment.

Clinical Effectiveness: Do They Produce Different Results?

Because valaciclovir converts to aciclovir in your body, both medications produce the same active antiviral compound at the site of infection. The key difference lies in achieving therapeutic drug levels more reliably with valaciclovir due to its enhanced absorption [2].

Clinical trials comparing episodic treatment of recurrent herpes labialis found that both medications significantly reduced healing time when started during the prodromal phase (tingling, itching before visible lesions appear). Studies show average healing time reduction of 1-2 days compared to placebo when treatment begins within 48 hours of symptom onset [3][4].

A systematic review published in the Journal of Antimicrobial Chemotherapy concluded that valaciclovir's improved pharmacokinetics may offer marginal benefits in convenience and adherence, but both drugs demonstrate equivalent clinical efficacy when patients take them correctly as prescribed [5]. The real-world effectiveness often depends more on how quickly you start treatment after noticing first symptoms than which specific antiviral you choose.

Side Effects and Safety Profile Comparison

Both aciclovir and valaciclovir share similar safety profiles, with most patients experiencing no side effects or only mild symptoms. The most commonly reported adverse effects include headache (affecting up to 13% of patients), nausea, and gastrointestinal discomfort [1][2].

Because valaciclovir produces higher peak plasma concentrations of aciclovir, some patients report slightly more frequent gastrointestinal symptoms compared to standard-dose oral aciclovir. However, clinical trial data shows the overall incidence of side effects remains low for both medications, with serious adverse events being rare [5].

Patients with reduced kidney function require dose adjustments for both medications, as aciclovir is primarily eliminated through renal excretion. Your UK prescriber will review your medical history and current medications during your online consultation to ensure safe prescribing. Adequate hydration is recommended when taking either antiviral, particularly at higher doses.

When to Contact Your Prescriber

Seek medical advice if you experience severe headache, confusion, unusual bruising or bleeding, or signs of allergic reaction (rash, difficulty breathing, facial swelling) while taking either medication. Most side effects are mild and resolve without intervention, but your healthcare team at Cured Pharmacy remains available on (+44) 116 4646009 if you have concerns during treatment.

Cost Considerations: Aciclovir vs Valaciclovir in the UK

Aciclovir has been available as a generic medication in the UK for decades, making it one of the most cost-effective antiviral treatments available. At Cured Pharmacy, Numark Cold Sore Cream containing aciclovir starts from £4.49, offering accessible over-the-counter treatment for mild cold sore outbreaks.

Prescription oral aciclovir tablets are available through our online consultation service, with pricing displayed upfront before you complete your clinical assessment. Valaciclovir, while more expensive per course than generic aciclovir, may offer better value for some patients when considering the convenience of twice-daily dosing and potentially improved adherence.

When evaluating cost-effectiveness, consider the total expense of a treatment course including your time and effort for medication administration. A slightly higher upfront cost for valaciclovir may prove worthwhile if the simplified dosing schedule helps you complete the full treatment course consistently, particularly for recurrent outbreaks requiring multiple treatment episodes per year.

Choosing Between Aciclovir and Valaciclovir: Clinical Recommendations

For most patients experiencing occasional cold sore outbreaks, standard aciclovir tablets or topical cream provide effective, affordable treatment when started at the first sign of symptoms. The five-times-daily dosing requires commitment, but clinical outcomes remain excellent with proper adherence [4].

Valaciclovir becomes particularly advantageous for patients with frequent recurrent outbreaks (six or more per year), those with adherence challenges to multiple daily doses, or individuals seeking the convenience of twice-daily dosing. Some prescribers also favour valaciclovir for immunocompromised patients who may benefit from higher systemic drug levels [5].

Your UK-registered prescriber will assess your outbreak frequency, lifestyle factors, previous treatment responses, and medical history during your free online consultation at Cured Pharmacy. Both medications require prescription for oral formulations, ensuring you receive appropriate clinical oversight and dosing guidance tailored to your individual circumstances. Treatment typically works best when started within 48 hours of noticing prodromal symptoms, so keeping a course of medication available for rapid initiation can significantly improve outcomes.

Getting Started with Treatment at Cured Pharmacy

Our online consultation takes under three minutes and is reviewed by UK-registered prescribers who specialise in antiviral therapy. You'll see transparent pricing before completing your assessment, receive discreet packaging, and can access our clinical team for any questions during treatment. Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical services to ensure you receive safe, evidence-based care for cold sore management.

Scientific References

1. Spruance, S. L., et al. (1990). Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrobial Agents and Chemotherapy, 34(7), 1340–1343. https://doi.org/10.1128/AAC.34.7.1340 [accessed 13 August 2026]
2. Soul-Lawton, J., et al. (1995). Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrobial Agents and Chemotherapy, 39(12), 2759–2764. https://doi.org/10.1128/AAC.39.12.2759 [accessed 13 August 2026]
3. Spruance, S. L., et al. (2003). Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis. Journal of the American Academy of Dermatology, 49(5), 855–862. https://doi.org/10.1016/S0190-9622(03)02094-X [accessed 13 August 2026]
4. Raborn, G. W., et al. (2002). Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials. Journal of the American Dental Association, 133(3), 303–309. https://doi.org/10.14219/jada.archive.2002.0165 [accessed 13 August 2026]
5. Cernik, C., et al. (2008). The treatment of herpes simplex infections: an evidence-based review. Archives of Internal Medicine, 168(11), 1137–1144. https://doi.org/10.1001/archinte.168.11.1137 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.